By Laura Diorella Islas Limiñana

This thesis seeks to develop a better understanding of the transnational behaviour of drug trafficking organisations (DTOs) by documenting the role that Mexican DTOs had in the cocaine trafficking to Europe after 2008. This was the year when the Italian authorities announced their discoveries that there were business interaction between the Mexican DTOs and the Italian mafia groups. At the same time the Italian authorities were announcing their findings, my literature review showed a lack of analysis and documentation regarding the transnationalization of Mexican DTOs to Europe.

While most of the literature focuses on the explanation of the cartels inside Mexico, my research question focused on clarifying whether or not the Mexican DTOs are expanding their cocaine trafficking activities to Europe. At this point I considered the reports of the Italian authorities that affirm that the Mexican DTOs are relevant drug trafficking intermediaries in the cocaine trafficking routes to Europe.

To answer my research question, and to systematically describe the evolution of DTOs, a qualitative methods approach was deployed (Mohajan, 2018) with a case study design adapted from Yin (2003). My analysis was carried out through the use of multiple triangulation techniques that helped me to collect and study different types of data to understand the subject. I collected empirical information through 28 interviews with security personnel with experience in countering Mexican DTOs or in the cocaine routes to Europe. The information gathered from the security personnel, complemented by official reports and open source information, was useful to answer my research question and test my hypothesis.

The analysis showed that despite Italian authorities’ claims and perceptions, the power of the Mexican cartels is very limited when talking about their presence and links in Europe, and resulted in four key findings. Firstly, that the perception of the Mexican DTOs as having trans-Atlantic powers is erroneous, because the evidence showed that there is no transatlantic expansion. Secondly, the analysis uncovered the internal, national and international variables that were observed to alter the evolution and behaviour of the Mexican DTOs. At the internal level, the variables included the loss of leadership and the grievances between groups. At the national level the identified variables were the democratic transitions, corruption and impunity networks. And at the international level the variables were the international drug demand, the changes in the international illicit world, the situation of governance and corruption in foreign countries and the geography of the region where the illicit business are taking place.

By: The European Monitoring Centre for Drugs and Drug Addiction
This report presents an analysis of the drug markets in the European Neighbourhood Policy-East (ENP-East) countries: Armenia, Azerbaijan, Belarus (1), Georgia, Moldova and Ukraine. It provides a top-level overview of the information available on drug production, trafficking, sale, use and harms, as well as exploring what is known about the drivers and facilitators of drug markets across the ENP-East region. It highlights drug-related threats and their potential implications for security and health. Due to its proximity as well as economic and social ties, developments in this region have potentially important implications for the EU. The analysis presented here focuses on the drug situation over the period 2018-2021, and specifically on key developments prior to the COVID-19 pandemic through to the end of 2021. However, Russia’s invasion of Ukraine in February 2022 and its potentially significant implications for the drug situationare also considered, although solid information to inform the analysis is lacking. The ENP-East region comprises two geographically distinct groups of countries separated by the Black Sea and Russia (Figure 1). While there are similarities in the drug markets across these countries, their geographical location has influenced their domestic drug situations, including production, trafficking, sales and use. In the north-western part of the ENP-East region lie Belarus, Moldova and Ukraine. These countries share borders with EU Member States, Russia and the Black Sea. In the south-eastern part of the region lie the Southern Caucasus countries, namely Armenia, Azerbaijan and Georgia. The Southern Caucasus borders Iran, Russia, Türkiye and the Black Sea. The drug markets in the region continues to undergo significant change in terms of the production, trafficking, sale and use of illicit drugs. A key recent development has been the growth of online markets, which has been linked with the availability of a broader spectrum of drugs, particularly new psychoactive substances (NPS). Thereported emergence of new trafficking routes for heroin and cocaine through the Black Sea, with involvement of international criminal networks, is another relatively recent phenomenon that highlights the need for continuing vigilance in this area. New developments have also been noted in drug production, with synthetic drug production sites identified and dismantled in several countries in the region. In addition, there are concerns that the Russian invasion of Ukraine in February 2022 may impact on drug flows and lead to increased drug-related harms, both in Ukraine and in neighbouring countries. The findings detailed in this report are based on semistructured interviews conducted between September and December 2021 with over 40 stakeholders in the six countries of the ENP-East region. Stakeholders included government representatives, law enforcement agencies, non-governmental organisations (NGOs), researchers and international organisations. To substantiate the information that emerged from these interviews, scientific literature and other data and reports published by governmental and non-governmental entities were consulted. However, it is important to note that in general there is a lack of routinely collected and detailed information on the drug situation in the region. This highlights the importance of strengthening routine drug monitoring data systems for collecting and reporting reliable and comparable information.